Evaluating pathologic response of breast cancer to neoadjuvant chemotherapy with computer-extracted features from contrast-enhanced ultrasound videos

Abstract

PurposeTo extract quantitative perfusion and texture features with computer assistance from contrast-enhanced ultrasound (CEUS) videos of breast cancer before and after neoadjuvant chemotherapy (NAC), and to evaluate pathologic response to NAC with these features. MethodsForty-two CEUS videos with 140,484 images were acquired from 21 breast cancer patients pre- and post-NAC. Time-intensity curve (TIC) features were calculated including the difference between area under TIC within a tumor and that within a computer-detected reference region (AUT_T-R). Four texture features were extracted including Homogeneity and Contrast. All patients were identified as pathologic responders by Miller and Payne criteria. The features between pre- and post-treatment in these responders were statistically compared, and the discrimination between pre- and post-treatment cancers was assessed with a receiver operating characteristic (ROC) curve. ResultsCompared with the pre-treatment cancers, the post-treatment cancers had significantly lower Homogeneity (p<0.001) and AUT_T-R (p=0.014), as well as higher Contrast (p<0.001), indicating the intratumoral contrast enhancement decreased and became more heterogeneous after NAC in responders. The combination of Homogeneity and AUT_T-R achieved an accuracy of 90.5% and area under ROC curve of 0.946 for discrimination between pre- and post-chemotherapy cancers without cross validation. The accuracy still reached as high as 85.7% under leave-one-out cross validation. ConclusionsThe computer-extracted CEUS features show reduced and more heterogeneous neovascularization of cancer after NAC. The features achieve high accuracy for discriminating between pre- and post-chemotherapy cancers in responders and thus are potentially valuable for tumor response evaluation in clinical practice.